Pharmaceutical Preparations·NORTH CHESTERFIELD, VA
Summary Financials
Revenue
$1.1B
+21.3% YoY
FY 2025
Adj. EBITDA
-$137.0M
-12.5% margin
FY 2025
Net Income
-$126.0M
-11.5% margin
FY 2025
EPS (Diluted)
-$0.92
FY 2025
Stock Price
$33.34
+2.3%
2026-03-10
52W Range
$8.64 – $38.00
P/E Ratio
-36.2x
Market Cap
$4.2B
Cash
$319.0M
FY 2025
Total Debt
$315.0M
FY 2025
Net Cash
$4.0M
FY 2025
Enterprise Value
$4.2B
Debt / EBITDA
0.0x
FY 2025
EV / EBITDA
-30.4x
Employees
—
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction.